Current Research

The scope of our research seeks to understand a wide array of issues specific to women's health, including reproduction, heart disease and determinants of preterm delivery, among many others. 

Maternal-Fetal Medicine

The Division of Maternal-Fetal Medicine is researching determinants of preterm delivery, early placental tissue, safety in childbirth and maternal severe morbidity. Calvin J. Hobel, MD, is analyzing the links between psychosocial and prenatal stresses and preterm delivery. The division has established a bio-repository for chorionic villa sampling (CVS) procedures. Cedars-Sinai is the only institution in the nation that stores placental tissue from the first trimester, so our researchers can investigate the origins of diseases that affect babies and mothers at the earliest stages of pregnancy.

Calvin J. Hobel, MD

Maternal Quality of Care

Kimberly D. Gregory, MD, MPH, has developed maternal quality of care indicators and linked vaginal birth after cesarean delivery policies on labor and delivery to birth outcomes. She continues to evaluate physician behavior and patient views of delivery as it impacts obstetric outcomes. 

Kimberly D. Gregory, MD, MPH

Maternal Morbidity

Sarah Kilpatrick, MD, PhD, has researched severe maternal morbidity evaluation and potential preventability and continues to work nationally on this area.

Sarah J. Kilpatrick, MD, PhD

Reproductive Endocrinology & Infertility

Led by Margareta D. Pisarska, MD, the Division of Reproductive Endocrinology and Infertility is researching the process of ovulation to determine why some women experience early menopause. Specific areas of research involve oocyte development, infertility and abnormalities in reproductive endocrinology, fibroids and premature ovarian failure.

Margareta D. Pisarska, MD

End of Life Care

Ilana Cass, MD, is developing programs to educate physicians and patients about end of life care.

Ilana Cass, MD

Women's Cancer

Ovarian Cancer: Initiation and Metastasis

Christine Walsh, MD, MS, is studying the genetic changes occurring in ovarian cancer DNA, with the goals of better defining the events that lead to ovarian cancer initiation and progression, and identifying novel therapeutic targets and treatments.

Christine Walsh, MD, MS

Sandra Orsulic, PhD, is working to understand the genetic and epigenetic changes that lead to the initiation and metastatic spread of ovarian cancer. She is generating suitable pre-clinical models for testing therapies that target specific biochemical pathways, and identifying recognizable histological or molecular markers that could be used for early cancer detection.

Sandra Orsulic, PhD

Current Research Areas

  • Ovarian Cancer
  • Reproductive Endocrinology & Fertility
Have Questions or Need Help?

Contact us if you have questions, or wish to learn more about women’s research at Cedars-Sinai.